124 related articles for article (PubMed ID: 2330609)
1. Morphological heterogeneity and phenotype modifications during long term in vitro cultures of six new human glioblastoma cell lines.
Dipasquale B; Colombatti M; Tridente G
Tumori; 1990 Apr; 76(2):172-8. PubMed ID: 2330609
[TBL] [Abstract][Full Text] [Related]
2. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 2 down-regulates HLA-DR antigen expression on human malignant glioma cells.
Zuber P; Kuppner MC; De Tribolet N
Eur J Immunol; 1988 Oct; 18(10):1623-6. PubMed ID: 3142781
[TBL] [Abstract][Full Text] [Related]
4. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.
Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD
J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines.
Colombatti M; Dipasquale B; Del-l'Arciprete L; Gerosa M; Tridente G
J Neurosurg; 1989 Sep; 71(3):388-97. PubMed ID: 2769391
[TBL] [Abstract][Full Text] [Related]
6. Antigen variation in a human glioblastoma: from the primary tumor to the second recurrence, permanent cell line and xenotransplantation tumors.
Bilzer T; Stavrou D; Wechsler W; Wöhler B; Keiditsch E
Anticancer Res; 1991; 11(2):547-53. PubMed ID: 2064311
[TBL] [Abstract][Full Text] [Related]
7. Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro.
Bilzer T; Stavrou D; Dahme E; Keiditsch E; Bürrig KF; Anzil AP; Wechsler W
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):281-93. PubMed ID: 1708926
[TBL] [Abstract][Full Text] [Related]
8. Patterns of antigenic expression of human glioma cells.
McKeever PE; Davenport RD; Shakui P
Crit Rev Neurobiol; 1991; 6(2):119-47. PubMed ID: 1934088
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
10. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.
Reifenberger G; Bilzer T; Seitz RJ; Wechsler W
Acta Neuropathol; 1989; 78(3):270-82. PubMed ID: 2475009
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases.
Koldovsky P; Haas I; Bier H; Ganzer U
Eur Arch Otorhinolaryngol; 1995; 252(6):359-65. PubMed ID: 8679156
[TBL] [Abstract][Full Text] [Related]
12. A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markers.
Shiras A; Bhosale A; Shepal V; Shukla R; Baburao VS; Prabhakara K; Shastry P
Neoplasia; 2003; 5(6):520-32. PubMed ID: 14965445
[TBL] [Abstract][Full Text] [Related]
13. Human glioma-associated antigens detected by monoclonal antibodies.
Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
[TBL] [Abstract][Full Text] [Related]
15. Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.
Carrel S; De Tribolet N; Gross N
Eur J Immunol; 1982 Apr; 12(4):354-7. PubMed ID: 6954072
[TBL] [Abstract][Full Text] [Related]
16. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation.
Dell'albani P; Rodolico M; Pellitteri R; Tricarichi E; Torrisi SA; D'Antoni S; Zappia M; Albanese V; Caltabiano R; Platania N; Aronica E; Catania MV
Neuro Oncol; 2014 Jan; 16(2):204-16. PubMed ID: 24305720
[TBL] [Abstract][Full Text] [Related]
17. Antigenic immunostaining patterns in somatic hybrids of human HeLa cells and mouse fibroblasts 3T3.4E propagated in conventional medium and delipidized serum.
Gallagher T; Chardonnet Y; Viac J; Patet J; Lefèvre A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(6):339-47. PubMed ID: 2481900
[TBL] [Abstract][Full Text] [Related]
18. A human glioma cell line retaining expression of GFAP and gangliosides, recognized by A2B5 and LB1 antibodies, after prolonged passage.
Knott JC; Edwards AJ; Gullan RW; Clarke TM; Pilkington GJ
Neuropathol Appl Neurobiol; 1990 Dec; 16(6):489-500. PubMed ID: 1982895
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties.
Molino A; Stevanoni G; Lorenzi P; Dipasquale B; Colombari R; Chilosi M; Cetto GL; Forni G; Gerosa M; Tridente G
Tumori; 1988 Apr; 74(2):151-5. PubMed ID: 3368969
[TBL] [Abstract][Full Text] [Related]
20. Expression of different immunological markers by cultured human melanocytes.
Smit N; Le Poole I; van den Wijngaard R; Tigges A; Westerhof W; Das P
Arch Dermatol Res; 1993; 285(6):356-65. PubMed ID: 8215585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
